Jia J S, Yang S M, Wang J, Jiang H, Zhao T, Bao L, Shi H X, Lu J, Zhu H H, Lai Y Y, Jiang B, Huang X J, Jiang Q
Peking University People's Hospital, Peking University Institute of Hematology 100044 Beijing, China.
Zhonghua Xue Ye Xue Za Zhi. 2016 Jun 14;37(6):497-502. doi: 10.3760/cma.j.issn.0253-2727.2016.06.011.
To investigate the prognostic significance of proportion of the blasts in bone marrow on day 14 (D14) during induction chemotherapy in patients with adult Ph-negative acute lymphoblastic leukemia (Ph (-) ALL).
Newly diagnosed Ph (-) ALL patients with bone marrow morphology analysis on day 14 during induction chemotherapy were analyzed retrospectively. The proportion of the D14 blasts which had an impact on achieving a CR by the first induction chemotherapy and outcomes were determined by ROC curve.
166 ALL patients including 94 male and 72 female were analyzed. The median age was 32 years (range, 18-64 years). The CR rate by the first induction chemotherapy was 74.7% with a total CR rate as 93.3%. By ROC analysis, 7.5% of the D14 blasts had the best sensitivity and specificity. The patients with D14 blasts ≥7.5% had lower CR rates after the first and overall induction chemotherapy compared with those with D14 blasts <7.5% (42.7% vs 85.9%, P<0.001 and 75.9% vs 95.6%, P=0.001 respectively). The probabilities of 5-year disease free survival (DFS) and 5-year overall survival (OS) were higher in the patients with D14 blasts<7.5% than those with D14 blasts ≥7.5% (49.8% vs 29.6%, P=0.006 and 52.4% vs 32.6%, P=0.010 respectively). Multivariate analysis showed that higher WBC or central nervous system leukemia at diagnosis, D14 blasts ≥7.5%, no CR after the first induction chemotherapy and receiving consolidation and maintenance chemotherapy rather than transplant were associated with poor outcomes.
Higher proportion of D14 blasts in bone marrow during the first induction therapy indicated poor prognosis in adult Ph(-) ALL.
探讨成人Ph阴性急性淋巴细胞白血病(Ph(-)ALL)患者诱导化疗第14天(D14)骨髓原始细胞比例的预后意义。
回顾性分析新诊断的Ph(-)ALL患者诱导化疗期间第14天的骨髓形态学分析结果。通过ROC曲线确定影响首次诱导化疗达到完全缓解(CR)及预后的D14原始细胞比例。
分析了166例ALL患者,其中男性94例,女性72例。中位年龄为32岁(范围18 - 64岁)。首次诱导化疗的CR率为74.7%,总CR率为93.3%。通过ROC分析,D14原始细胞比例为7.5%时具有最佳的敏感性和特异性。D14原始细胞比例≥7.5%的患者首次及总体诱导化疗后的CR率低于D14原始细胞比例<7.5%的患者(分别为42.7%对85.9%,P<0.001;75.9%对95.6%,P = 0.001)。D14原始细胞比例<7.5%的患者5年无病生存率(DFS)和5年总生存率(OS)的概率高于D14原始细胞比例≥7.5%的患者(分别为49.8%对29.6%,P = 0.006;52.4%对32.6%,P = 0.010)。多因素分析显示,诊断时白细胞计数较高或存在中枢神经系统白血病、D14原始细胞比例≥7.5%、首次诱导化疗后未达到CR以及接受巩固和维持化疗而非移植与不良预后相关。
首次诱导治疗期间骨髓中D14原始细胞比例较高提示成人Ph(-)ALL预后不良。